vs

Side-by-side financial comparison of CME Group (CME) and Monster Beverage (MNST). Click either name above to swap in a different company.

Monster Beverage is the larger business by last-quarter revenue ($2.1B vs $1.9B, roughly 1.1× CME Group). Monster Beverage runs the higher net margin — 21.1% vs 0.1%, a 21.0% gap on every dollar of revenue. On growth, Monster Beverage posted the faster year-over-year revenue change (17.6% vs 14.5%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 5.9%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless, Reign and Burn. The company was originally founded as Hansen's in 1935 in Southern California, originally selling juice products. The company renamed itself as Monster Beverage in 2012.

CME vs MNST — Head-to-Head

Bigger by revenue
MNST
MNST
1.1× larger
MNST
$2.1B
$1.9B
CME
Growing faster (revenue YoY)
MNST
MNST
+3.1% gap
MNST
17.6%
14.5%
CME
Higher net margin
MNST
MNST
21.0% more per $
MNST
21.1%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
5.9%
MNST

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
MNST
MNST
Revenue
$1.9B
$2.1B
Net Profit
$1.2M
$449.2M
Gross Margin
55.5%
Operating Margin
0.1%
25.5%
Net Margin
0.1%
21.1%
Revenue YoY
14.5%
17.6%
Net Profit YoY
20.7%
65.9%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
MNST
MNST
Q1 26
$1.9B
Q4 25
$1.6B
$2.1B
Q3 25
$1.5B
$2.2B
Q2 25
$1.7B
$2.1B
Q1 25
$1.6B
$1.9B
Q4 24
$1.5B
$1.8B
Q3 24
$1.6B
$1.9B
Q2 24
$1.5B
$1.9B
Net Profit
CME
CME
MNST
MNST
Q1 26
$1.2M
Q4 25
$1.2B
$449.2M
Q3 25
$908.0M
$524.5M
Q2 25
$1.0B
$488.8M
Q1 25
$956.2M
$443.0M
Q4 24
$874.6M
$270.7M
Q3 24
$912.8M
$370.9M
Q2 24
$883.2M
$425.4M
Gross Margin
CME
CME
MNST
MNST
Q1 26
Q4 25
55.5%
Q3 25
55.7%
Q2 25
55.7%
Q1 25
56.5%
Q4 24
55.3%
Q3 24
53.2%
Q2 24
53.6%
Operating Margin
CME
CME
MNST
MNST
Q1 26
0.1%
Q4 25
61.8%
25.5%
Q3 25
63.3%
30.7%
Q2 25
66.7%
29.9%
Q1 25
67.5%
30.7%
Q4 24
62.1%
21.0%
Q3 24
64.6%
25.5%
Q2 24
65.3%
27.7%
Net Margin
CME
CME
MNST
MNST
Q1 26
0.1%
Q4 25
71.7%
21.1%
Q3 25
59.1%
23.9%
Q2 25
60.6%
23.1%
Q1 25
58.2%
23.9%
Q4 24
57.3%
14.9%
Q3 24
57.6%
19.7%
Q2 24
57.6%
22.4%
EPS (diluted)
CME
CME
MNST
MNST
Q1 26
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
MNST
MNST
Cash + ST InvestmentsLiquidity on hand
$2.4B
$2.8B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$8.3B
Total Assets
$202.0B
$10.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
MNST
MNST
Q1 26
$2.4B
Q4 25
$4.5B
$2.8B
Q3 25
$2.6B
$2.6B
Q2 25
$2.1B
$2.1B
Q1 25
$1.5B
$1.9B
Q4 24
$3.0B
$1.5B
Q3 24
$2.4B
$1.6B
Q2 24
$1.9B
$1.6B
Total Debt
CME
CME
MNST
MNST
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
$199.1M
Q4 24
$374.0M
Q3 24
$748.8M
Q2 24
$748.7M
Stockholders' Equity
CME
CME
MNST
MNST
Q1 26
Q4 25
$28.7B
$8.3B
Q3 25
$28.2B
$7.7B
Q2 25
$27.7B
$7.2B
Q1 25
$27.0B
$6.5B
Q4 24
$26.5B
$6.0B
Q3 24
$28.2B
$5.8B
Q2 24
$27.6B
$5.9B
Total Assets
CME
CME
MNST
MNST
Q1 26
$202.0B
Q4 25
$198.4B
$10.0B
Q3 25
$187.1B
$9.6B
Q2 25
$179.9B
$8.7B
Q1 25
$157.8B
$8.2B
Q4 24
$137.4B
$7.7B
Q3 24
$137.8B
$8.1B
Q2 24
$123.4B
$8.1B
Debt / Equity
CME
CME
MNST
MNST
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
0.03×
Q4 24
0.06×
Q3 24
0.13×
Q2 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
MNST
MNST
Operating Cash FlowLast quarter
$379.4M
Free Cash FlowOCF − Capex
$351.2M
FCF MarginFCF / Revenue
16.5%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
0.84×
TTM Free Cash FlowTrailing 4 quarters
$2.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
MNST
MNST
Q1 26
Q4 25
$1.1B
$379.4M
Q3 25
$968.1M
$745.1M
Q2 25
$1.1B
$466.0M
Q1 25
$1.1B
$507.6M
Q4 24
$1.0B
$461.7M
Q3 24
$1.0B
$618.4M
Q2 24
$776.9M
$436.3M
Free Cash Flow
CME
CME
MNST
MNST
Q1 26
Q4 25
$1.1B
$351.2M
Q3 25
$949.7M
$701.5M
Q2 25
$1.0B
$434.6M
Q1 25
$1.1B
$478.5M
Q4 24
$991.7M
$370.4M
Q3 24
$973.2M
$571.4M
Q2 24
$758.7M
$376.5M
FCF Margin
CME
CME
MNST
MNST
Q1 26
Q4 25
66.8%
16.5%
Q3 25
61.8%
31.9%
Q2 25
61.5%
20.6%
Q1 25
67.1%
25.8%
Q4 24
65.0%
20.4%
Q3 24
61.4%
30.4%
Q2 24
49.5%
19.8%
Capex Intensity
CME
CME
MNST
MNST
Q1 26
Q4 25
2.0%
1.3%
Q3 25
1.2%
2.0%
Q2 25
1.1%
1.5%
Q1 25
0.9%
1.6%
Q4 24
1.7%
5.0%
Q3 24
1.9%
2.5%
Q2 24
1.2%
3.1%
Cash Conversion
CME
CME
MNST
MNST
Q1 26
Q4 25
0.96×
0.84×
Q3 25
1.07×
1.42×
Q2 25
1.03×
0.95×
Q1 25
1.17×
1.15×
Q4 24
1.16×
1.71×
Q3 24
1.10×
1.67×
Q2 24
0.88×
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

MNST
MNST

Monster Energy Drinks Segment$1.2B57%
Sales Revenue Product Line$905.5M42%
Strategic Brands Segment$50.3M2%
Alcohol Brands Segment$29.0M1%

Related Comparisons